EFTA Document EFTA01518838

CH ISLAINE MAXWELL - OAP IHD ACCT. For the Period 8/1/I3 to sain3 TRADE ACTIVITY Note: S indicates Short Term Realized Gain/Loss • Settled transaction was initiated in prior statement period and settled in current statement period Trade Date Type Settle Date Selection Method Description Per Unit Realized Quantity Amount Proceeds Tax Cost Gain/Loss Settled Sales/Maturities/Redemptlons 7131 Sale PETROCHINA CO LTD ADR . 117.5488 28,799.46 (245.000) 117.507 28,789.15 (33,348.03) (4,556.88) S. 8/5 High Cost BROKERAGE 9.80 TAX 8/OR SEC .51 ESI SECURITIES COMPANY (ID: 71848E-10-0) 8/8 Sale ISRAEL CHEMICALS LTD ADR a 7.7855 6,734.46 (865.000) 7.785 8,717.04 (11,631.86) (4,914.82) S 8/9 High Cost BROKERAGE 17.30 TAX 8/OR SEC .12 ESI SECURES COMPANY (ID: 465036-20-0) 8/6 Sale ROYAL DUTCH SHELL PLC ADR a 86.9621 6,696.21 (100.000) 66.921 6,692.09 (6.980.35) (268.26) S 8/9 High Cost BROKERAGE 4.00 TAX 8/OR SEC .12 ESI SECURITIES COMPANY WASH SALE ADJUSTMENT C6/09/13 (ID: 780259-104) 8/7 Sale ISRAEL CHEMICALS LTD ADR a 7.8068 5,386.69 (690.000) 7.787 5,372.79 (9,266.70) (3,893.91) S fY12 High Cost BROKERAGE 13.80 TAX 8/OR SEC .10 ESI SECURITIES COMPANY (ID: 465036-20-0) 8/7 Sale ROYAL DUTCH SHELL PLC ADR @ 67.1803 5,038.52 (75.000) 67.139 5,035.43 (5.780.M (744.60) S 8/12 High Cost BROKERAGE 3.00 TAX 8/OR SEC .09 ESI SECURITIES COMPANY (ID: 780259-10-7) 8/8 Sale ISRAEL CHEMICALS LTD ADR a 7.9179 3,840.18 (485.000) 7.898 3,830.41 (6,513.55) (2,683.14) S 8/13 High Cost BROKERAGE 9.70 TAX 8/OR SEC .07 ESI SECURITIES COMPANY (ID: 465036-20-0) 8/16 Sale BOC HONG KONG HOLDINGS LTD SPONS ADR a 63.8153 (225.000) 63.774 14,349.19 (15,648.48) (1.257.29) S 8/21 High Cost 14,358.44 BROKERAGE 9.00 TAX 8/OR SEC .25 ESI SECURITIES COMPANY (ID: 096813-20-9) 816 Sale TELEKOMUNIKASI IND SPONS ADR a 43.9722 659.58 (15.000) 43.931 658.96 (732.90) (73.94) 5 8/21 High Cost BROKERAGE 0.60 TAX 8/OR SEC .02 ESI SECURITIES COMPANY (ID: 715684-104) J.P. Morgan Account Page 12 of 15 Consolidated Statement Page 56 Confidential Treatment Requested by JPMorgan Chase CONFIDENTIAL JPM-SDNY-00046091 SDNY_GM_00315289 EFTA01518838